




Searching News Database: DME
HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
HSMN NewsFeed - 7 Jul 2020
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
HSMN NewsFeed - 18 Feb 2020
LumiThera to Expand Research into Diabetic Retinopathy for Valeda(R) Light Delivery System
LumiThera to Expand Research into Diabetic Retinopathy for Valeda(R) Light Delivery System
HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
HSMN NewsFeed - 29 Nov 2016
KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific Officer
KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 23 Mar 2016
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
Envisia Therapeutics Secures $16.5 Million In Additional Series A Financing
HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
HSMN NewsFeed - 24 Apr 2012
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
HSMN NewsFeed - 17 Jun 2010
Study Demonstrates that IRIDEX MicroPulse Laser Effectively Treats Eyes with Diabetic Macular Edema
Study Demonstrates that IRIDEX MicroPulse Laser Effectively Treats Eyes with Diabetic Macular Edema
HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
HSMN NewsFeed - 6 May 2008
Daxor Announces Kaiser Permanente of Los Angeles, CA Purchases BVA-100 Blood Volume Analyzer
Daxor Announces Kaiser Permanente of Los Angeles, CA Purchases BVA-100 Blood Volume Analyzer
HSMN NewsFeed - 24 Mar 2008
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
HSMN NewsFeed - 18 Mar 2008
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
HSMN NewsFeed - 27 Jun 2007
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
HSMN NewsFeed - 26 Dec 2006
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
HSMN NewsFeed - 27 Nov 2006
Alimera Sciences Completes Second Tranche of Series B Financing, Receives $15.9 Million
Alimera Sciences Completes Second Tranche of Series B Financing, Receives $15.9 Million
HSMN NewsFeed - 24 Oct 2006
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
HSMN NewsFeed - 18 Oct 2006
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
HSMN NewsFeed - 26 May 2006
Daxor Announces Palmetto Health Baptist Columbia of Columbia, SC Purchases Blood Volume Analyzer BVA-100
Daxor Announces Palmetto Health Baptist Columbia of Columbia, SC Purchases Blood Volume Analyzer BVA-100
HSMN NewsFeed - 25 May 2006
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
pSivida Provides Update on BrachySil(TM) Liver Program: Expansion of Multicenter Clinical Trial
HSMN NewsFeed - 25 Apr 2006
Sorenson Medical ambIT Pumps Offer Unique Reimbursable Solution to Rising Pain Management Medical Costs
Sorenson Medical ambIT Pumps Offer Unique Reimbursable Solution to Rising Pain Management Medical Costs
HSMN NewsFeed - 20 Mar 2006
Data Safety Monitoring Board Recommends Continuation of Medidur(TM) Phase 3 Clinical Trial
Data Safety Monitoring Board Recommends Continuation of Medidur(TM) Phase 3 Clinical Trial
HSMN NewsFeed - 13 Mar 2006
Daxor Announces Medical University of South Carolina Acquires Blood Volume Analyzer BVA-100
Daxor Announces Medical University of South Carolina Acquires Blood Volume Analyzer BVA-100
Additional items found! 19

Members Archive contains
19 additional stories matching:
DME
(Password required)
DME
(Password required)